Ambien Side Effects Lawsuit
Ambien, a non-benzodiazepine hypnotic of the imidazopyridine class, is available in 5 and 10mg strength tablets to be taken orally. Ambien is used to treat insomnia and has been shown to decrease sleep latency for up to 35 days in clinical studies.
The dose recommended for adults is 10mg once daily right before bedtime and elderly or debilitated patients are recommended only 5mg per day. Eldery and debilitated patients may be particularly sensitive to zolpidem tartate effects. Ambien dose should not ever exceed a total of 10mg per day. If taken during ingestion or immediately after a meal the effect of Ambien may be slowed.
Ambien is available in 5 and 10 mg strength tablets to be used for oral administration. The 5mg tablets are pink, capsule-shaped, film coated, and have AMB 5 imprinted on one side and 5401 on the other. The 10mg tablets are white, capsule-shaped, film coated, and have AMB 10mg imprinted on one side and 5421 on the reverse side. The capsules are to be stored at room temperature.
The following side effects are associated with Ambien
- Serious anaphylactic and anaphylactoid reactions
- Behavior changes
- Abnormal thinking
- Withdrawl effects
- CNS-depressant effects
- Dry mouth
- Back Pain
- Influenza-like symptoms
- Chest pain
- Drugged feeling
- Abnormal dreams
- Sleep disorder
- Abdominal pain
Symptomatic treatment of insomnia should only be administered after careful evaluation of the patient. If after 7 to 10 days of treatment the insomnia fails to remit, the patient should be evaluated for the presence of a primary psychiatric and or mental illness. If the insomnia gets worse or new thinking or behavior abnormalities emerge, it may be the result of an unrecognized psychiatric or physical disorder.
A variety of behavior changes and abnormalities have been reported in association of sedative-hypnotics, some of which may be described by decreased reticence comparable to effects of alcohol and other CNS depressants. Sleep driving and other complex behaviors have also been reported with the use of sedative-hypnotics.